Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Imre Noth

Showing results (51-60 of 211) with videos related to

Pageof 22
Sort By:
European Radiology|July 9, 2017
CT findings associated with survival in chronic hypersensitivity pneumonitisJonathan H Chung, Steven M Montner, Ayodeji Adegunsoye, et al.
The Lancet. Respiratory Medicine|January 17, 2014
Anti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomised controlled trialsJoyce S Lee, Harold R Collard, Kevin J Anstrom, et al.
Chest|November 29, 2023
Comparison of Pirfenidone and Nintedanib: Post Hoc Analysis of the CleanUP-IPF StudyJohn S Kim, Susan Murray, Eric Yow, et al.
American Journal of Respiratory and Critical Care Medicine|May 8, 2012
A placebo-controlled randomized trial of warfarin in idiopathic pulmonary fibrosisImre Noth, Kevin J Anstrom, Sara Bristol Calvert, et al.
American Journal of Respiratory and Critical Care Medicine|September 17, 2019
Circulating Plasma Biomarkers of Progressive Interstitial Lung DiseaseShehabaldin Alqalyoobi, Ayodeji Adegunsoye, Angela Linderholm, et al.
Annals of the American Thoracic Society|January 18, 2019
Computed Tomography Honeycombing Identifies a Progressive Fibrotic Phenotype with Increased Mortality across Diverse Interstitial Lung DiseasesAyodeji Adegunsoye, Justin M Oldham, Shashi K Bellam, et al.
American Journal of Respiratory and Critical Care Medicine|December 20, 2018
Telomere Length and Use of Immunosuppressive Medications in Idiopathic Pulmonary FibrosisChad A Newton, David Zhang, Justin M Oldham, et al.
Chest|May 4, 2019
Association of Angiotensin Modulators With the Course of Idiopathic Pulmonary FibrosisMichael Kreuter, David J Lederer, Maria Molina-Molina, et al.
Respiratory Medicine|January 23, 2019
Anti-RNA binding protein positivity in idiopathic interstitial pneumoniaRene S Bermea, Ayodeji Adegunsoye, Justin Oldham, et al.
ERJ Open Research|December 17, 2024
Effects of nintedanib on circulating biomarkers of idiopathic pulmonary fibrosisR Gisli Jenkins, Vincent Cottin, Yasuhiko Nishioka, et al.
Pageof 22

Showing results (51-60 of 211) with videos related to

Sort By:
Pageof 22
European Radiology|July 9, 2017
CT findings associated with survival in chronic hypersensitivity pneumonitisJonathan H Chung, Steven M Montner, Ayodeji Adegunsoye, et al.
The Lancet. Respiratory Medicine|January 17, 2014
Anti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomised controlled trialsJoyce S Lee, Harold R Collard, Kevin J Anstrom, et al.
Chest|November 29, 2023
Comparison of Pirfenidone and Nintedanib: Post Hoc Analysis of the CleanUP-IPF StudyJohn S Kim, Susan Murray, Eric Yow, et al.
American Journal of Respiratory and Critical Care Medicine|May 8, 2012
A placebo-controlled randomized trial of warfarin in idiopathic pulmonary fibrosisImre Noth, Kevin J Anstrom, Sara Bristol Calvert, et al.
American Journal of Respiratory and Critical Care Medicine|September 17, 2019
Circulating Plasma Biomarkers of Progressive Interstitial Lung DiseaseShehabaldin Alqalyoobi, Ayodeji Adegunsoye, Angela Linderholm, et al.
Annals of the American Thoracic Society|January 18, 2019
Computed Tomography Honeycombing Identifies a Progressive Fibrotic Phenotype with Increased Mortality across Diverse Interstitial Lung DiseasesAyodeji Adegunsoye, Justin M Oldham, Shashi K Bellam, et al.
American Journal of Respiratory and Critical Care Medicine|December 20, 2018
Telomere Length and Use of Immunosuppressive Medications in Idiopathic Pulmonary FibrosisChad A Newton, David Zhang, Justin M Oldham, et al.
Chest|May 4, 2019
Association of Angiotensin Modulators With the Course of Idiopathic Pulmonary FibrosisMichael Kreuter, David J Lederer, Maria Molina-Molina, et al.
Respiratory Medicine|January 23, 2019
Anti-RNA binding protein positivity in idiopathic interstitial pneumoniaRene S Bermea, Ayodeji Adegunsoye, Justin Oldham, et al.
ERJ Open Research|December 17, 2024
Effects of nintedanib on circulating biomarkers of idiopathic pulmonary fibrosisR Gisli Jenkins, Vincent Cottin, Yasuhiko Nishioka, et al.
Pageof 22